aTyr Pharma Ord Shs: Unternehmensprofil, Finanzberichte & Marktperformance

mehr Informationen über aTyr Pharma Ord Shs Unternehmen

Ethos Technologies Inc. is a United States-based life insurance company. The Company offers whole life insurance and term life insurance. Its whole life insurance provides accidental death benefit and death benefit. Its term life insurance offers monthly payment of premiums that do not increase during the term. It is provided for age 65-85 years. Its term life insurance provides coverage for a term typically 10-30 years. The Company operates in every United States and the District of Columbia.

aTyr Pharma Ord Shs Informationen



BörsenkürzelLIFE

Name des UnternehmensEthos Technologies Inc

IPO-datumMay 07, 2015

CEOColis (Peter George)

Anzahl der mitarbeiter- -

WertpapierartOrdinary Share

GeschäftsjahresendeMay 07

Addresse1606 Headway Circle

StadtAUSTIN

BörseNASDAQ OMX - NASDAQ BASIC

LandUnited States of America

Postleitzahl78754

Telefon13026365400

Websitehttps://www.ethos.com/

BörsenkürzelLIFE

IPO-datumMay 07, 2015

CEOColis (Peter George)

Führungskräfte von aTyr Pharma Ord Shs



Name

Name/Position

Position

Aktienbesitz

Veränderung

Dr. Sanjay S. Shukla, M.D.

President, Chief Executive Officer, Director

153.55K

+4.32%

Mr. Timothy P. (Tim) Coughlin, CPA

Independent Chairman of the Board

56.00K

+89.29%

Dr. Jane A. Gross, Ph.D.

Independent Director

9.75K

+38.46%

Dr. Svetlana Lucas, Ph.D.

Independent Director

6.00K

--

Dr. Paul R. Schimmel, Ph.D.

Independent Director

--

Ms. Jill M. Broadfoot

Chief Financial Officer

--

Ms. Nancy E. Denyes, J.D.

General Counsel, Corporate Secretary

--

Dr. Sara A. Zaknoen, M.D.

Independent Director

--

Mr. Peter Colis

Co-Founder, Chairman of the Board of Director, Chief Executive Officer

--

Mr. Lingke Wang

Co-Founder, Director, President

--

Name

Name/Position

Position

Aktienbesitz

Veränderung

Dr. Sanjay S. Shukla, M.D.

President, Chief Executive Officer, Director

153.55K

+4.32%

Mr. Timothy P. (Tim) Coughlin, CPA

Independent Chairman of the Board

56.00K

+89.29%

Dr. Jane A. Gross, Ph.D.

Independent Director

9.75K

+38.46%

Dr. Svetlana Lucas, Ph.D.

Independent Director

6.00K

--

Dr. Paul R. Schimmel, Ph.D.

Independent Director

--

Ms. Jill M. Broadfoot

Chief Financial Officer

--

Umsatzaufteilung

Relevante Daten wurden vom Unternehmen noch nicht offengelegt.

Relevante Daten wurden vom Unternehmen noch nicht offengelegt.

Nach Geschäftsbereich

Nach Region

Relevante Daten wurden vom Unternehmen noch nicht offengelegt.

Aktionärsstatistik

Aktualisiert: Fri, Feb 20

Aktionäre

Aktionärstypen

Aktionäre

Anteil

Fidelity Management & Research Company LLC

15.00%

Federated Hermes Global Investment Management Corp.

10.76%

BlackRock Institutional Trust Company, N.A.

6.10%

The Vanguard Group, Inc.

5.06%

State Street Investment Management (US)

4.28%

Andere

58.79%

Aktionäre

Anteil

Fidelity Management & Research Company LLC

15.00%

Federated Hermes Global Investment Management Corp.

10.76%

BlackRock Institutional Trust Company, N.A.

6.10%

The Vanguard Group, Inc.

5.06%

State Street Investment Management (US)

4.28%

Andere

58.79%

Aktionärstypen

Aktionäre

Anteil

Venture Capital

24.49%

Individual Investor

12.09%

Investment Advisor

10.75%

Investment Advisor/Hedge Fund

0.79%

Andere

51.88%

Institutionelle Beteiligung



Aktualisiert: Fri, Jan 30

Berichtszeitraum

Anzahl der Institutionen

Gehaltenen Aktien

Anteil

Veränderung

2026Q1

240

61.49M

62.75%

-12.15M

2025Q4

244

60.50M

61.75%

-16.64M

2025Q3

241

62.16M

63.44%

-11.39M

2025Q2

207

66.51M

74.72%

-166.29K

2025Q1

151

62.77M

70.80%

+2.91M

2024Q4

133

55.86M

66.65%

-3.11M

2024Q3

108

48.56M

65.39%

-7.43M

2024Q2

103

48.81M

71.98%

+527.76K

2024Q1

101

42.52M

63.83%

-4.61M

2023Q4

100

41.92M

72.67%

-1.23M

Aktionärsaktivitäten



Name

Gehaltenen Aktien

Anteil

Veränderung

Änderung%

Datum

Fidelity Management & Research Company LLC

14.70M

15%

+1.35M

+10.09%

Sep 30, 2025

Federated Hermes Global Investment Management Corp.

10.54M

10.76%

-4.12M

-28.11%

Sep 30, 2025

BlackRock Institutional Trust Company, N.A.

5.98M

6.1%

+635.14K

+11.89%

Sep 30, 2025

The Vanguard Group, Inc.

4.96M

5.06%

-669.06K

-11.88%

Dec 31, 2025

State Street Investment Management (US)

4.20M

4.28%

+2.96M

+238.49%

Sep 30, 2025

GSA Capital Partners LLP

706.73K

0.72%

+210.44K

+42.40%

Sep 30, 2025

Geode Capital Management, L.L.C.

2.18M

2.22%

+80.13K

+3.82%

Sep 30, 2025

Millennium Management LLC

1.89M

1.93%

+290.72K

+18.17%

Sep 30, 2025

UBS Financial Services, Inc.

4.34M

4.43%

+2.59M

+148.61%

Sep 30, 2025

Schimmel (Paul R Ph.D.)

1.10M

1.12%

+100.00K

+9.99%

Mar 01, 2025

Verbundene ETFs



Aktualisiert: Fri, Jan 30

Name

Anteil

iShares Micro-Cap ETF

0.01%

ProShares Hedge Replication ETF

0%

Global X Russell 2000 ETF

0%

Invesco Dorsey Wright SmallCap Momentum ETF

0%

iShares Russell 2000 Value ETF

0%

Vanguard US Momentum Factor ETF

0%

Pacer WealthShield ETF

0%

Direxion Daily S&P Biotech Bull 3X Shares

0%

Avantis US Small Cap Equity ETF

0%

ProShares UltraPro Russell2000

0%

iShares Micro-Cap ETF

Anteil0.01%

ProShares Hedge Replication ETF

Anteil0%

Global X Russell 2000 ETF

Anteil0%

Invesco Dorsey Wright SmallCap Momentum ETF

Anteil0%

iShares Russell 2000 Value ETF

Anteil0%

Vanguard US Momentum Factor ETF

Anteil0%

Pacer WealthShield ETF

Anteil0%

Direxion Daily S&P Biotech Bull 3X Shares

Anteil0%

Avantis US Small Cap Equity ETF

Anteil0%

ProShares UltraPro Russell2000

Anteil0%

Dividende



In den vergangenen 5 Jahren wurden insgesamt 0.00 USD an Dividenden ausgeschüttet.

Datum

Dividende

Stichtag für die Aktienregistrierung

Zahltag

Ex-Dividendentag

Keine Daten

Aktien-Split



Datum

Ex-Dividendentag

Art

Verhältnis

Keine Daten

Datum

Ex-Dividendentag

Art

Verhältnis

Keine Daten